14.73
price down icon18.89%   -3.43
after-market Handel nachbörslich: 14.72 -0.010 -0.07%
loading
Schlusskurs vom Vortag:
$18.16
Offen:
$15.86
24-Stunden-Volumen:
130.47K
Relative Volume:
8.88
Marktkapitalisierung:
$1.04B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$14.36
$17.90
1-Wochen-Bereich:
Value
$12.51
$23.94
52-Wochen-Spanne:
Value
$12.51
$23.94

Yd Bio Ltd Stock (YDES) Company Profile

Name
Firmenname
Yd Bio Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
YDES's Discussions on Twitter

Vergleichen Sie YDES mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
YDES
Yd Bio Ltd
14.73 956.80M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Yd Bio Ltd Aktie (YDES) Neueste Nachrichten

pulisher
Sep 04, 2025

Why Did YD Bio Plunge 14.37% Despite Revenue Growth? - AInvest

Sep 04, 2025
pulisher
Sep 03, 2025

Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday - Benzinga

Sep 03, 2025
pulisher
Sep 03, 2025

YD Bio Limited shares rise 7.33% premarket after being added to NASDAQ. - AInvest

Sep 03, 2025
pulisher
Sep 01, 2025

YD Bio Stock Fuels Retail-Trader Excitement After Nasdaq Listing Through Breeze SPAC Deal - Asianet Newsable

Sep 01, 2025
pulisher
Sep 01, 2025

YD Bio Limited Announces Closing of Business Combination - citybiz

Sep 01, 2025
pulisher
Aug 29, 2025

YDESBreeze Holdings Latest Stock News & Market Updates - Stock Titan

Aug 29, 2025
pulisher
Aug 29, 2025

YD Bio's Nasdaq Debut: A Strategic SPAC Merger Positions the Biotech Innovator for High-Growth Catalysts - AInvest

Aug 29, 2025
pulisher
Aug 29, 2025

Nasdaq: YD Bio Completes Merger With Breeze - AInvest

Aug 29, 2025
pulisher
Aug 29, 2025

YD Bio Shares to Begin Trading on Nasdaq After Completing Merger With Breeze - MarketScreener

Aug 29, 2025
pulisher
Aug 29, 2025

YD Bio Limited begins trading on Nasdaq under YDES, YDESW symbols. - AInvest

Aug 29, 2025
pulisher
Aug 28, 2025

YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market - GlobeNewswire

Aug 28, 2025
pulisher
Aug 15, 2025

Taiwan Biotech YD Biopharma Secures Path to Nasdaq Through Breeze Holdings SPAC Merger Approval - Stock Titan

Aug 15, 2025
pulisher
May 21, 2025

Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan - BioSpectrum Asia

May 21, 2025
pulisher
Apr 11, 2025

Reproductive adaptation of Astyanax mexicanus under nutrient limitation - ScienceDirect.com

Apr 11, 2025
pulisher
Sep 25, 2024

Breeze Holdings Acquisition Corp. Announces Definitive Agreement to Merge with YD Biopharma Limited - GlobeNewswire

Sep 25, 2024
pulisher
Sep 04, 2024

MARKET DATA - The Wall Street Journal

Sep 04, 2024
pulisher
Jul 08, 2024

US Share Prices - London South East

Jul 08, 2024
pulisher
Apr 09, 2024

From neural tube to spinal cord: The dynamic journey of the dorsal neuroepithelium - ScienceDirect.com

Apr 09, 2024
pulisher
Feb 03, 2023

The heparan sulfate modification enzyme, Hs6st1, governs Xenopus neuroectodermal patterning by regulating distributions of Fgf and Noggin - ScienceDirect.com

Feb 03, 2023
pulisher
May 02, 2022

A fishy tail: Insights into the cell and molecular biology of neuromesodermal cells from zebrafish embryos - ScienceDirect.com

May 02, 2022
pulisher
Mar 04, 2022

Hormone-related genes heterochronically and modularly regulate neotenic differentiation in termites - ScienceDirect.com

Mar 04, 2022
pulisher
Mar 04, 2022

Heads or tails: making the spinal cord - ScienceDirect.com

Mar 04, 2022
pulisher
Dec 21, 2021

A novel gene trap line for visualization and manipulation of erbb3b+ neural crest and glial cells in zebrafish - ScienceDirect.com

Dec 21, 2021
pulisher
Oct 16, 2021

Transcriptional and epigenetic regulation of temporal patterning in neural progenitors - ScienceDirect.com

Oct 16, 2021
pulisher
Sep 17, 2021

E-liquids and vanillin flavoring disrupts retinoic acid signaling and causes craniofacial defects in Xenopus embryos - ScienceDirect.com

Sep 17, 2021
pulisher
Aug 19, 2021

YAP/TAZ maintain the proliferative capacity and structural organization of radial glial cells during brain development - ScienceDirect.com

Aug 19, 2021
pulisher
Dec 11, 2020

Multi-tissue patterning drives anterior morphogenesis of the C. elegans embryo - ScienceDirect.com

Dec 11, 2020
pulisher
Jul 01, 2020

WNT signalling supported by MEK/ERK inhibition is essential to maintain pluripotency in bovine preimplantation embryo - ScienceDirect.com

Jul 01, 2020
pulisher
Apr 24, 2019

U.S. STOCKS - The Wall Street Journal

Apr 24, 2019
pulisher
Jul 19, 2017

Markets Today — Quotes, Charts, and Events - TradingView

Jul 19, 2017
pulisher
Jun 01, 2017

Ovaries of the white worm (Enchytraeus albidus, Annelida, Clitellata) are composed of 16-celled meroistic germ-line cysts - ScienceDirect.com

Jun 01, 2017
pulisher
Nov 01, 2016

Volvox: A simple algal model for embryogenesis, morphogenesis and cellular differentiation - ScienceDirect.com

Nov 01, 2016
pulisher
Jan 01, 2016

Msxb is a core component of the genetic circuitry specifying the dorsal and ventral neurogenic midlines in the ascidian embryo - ScienceDirect.com

Jan 01, 2016
pulisher
Aug 01, 2009

The causes of repeated genetic evolution - ScienceDirect.com

Aug 01, 2009
pulisher
Aug 15, 2008

Doublesex establishes sexual dimorphism in the Drosophila central nervous system in an isoform-dependent manner by directing cell number - ScienceDirect.com

Aug 15, 2008

Finanzdaten der Yd Bio Ltd-Aktie (YDES)

Es liegen keine Finanzdaten für Yd Bio Ltd (YDES) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):